Lexaria Bioscience

09 November, 2017 Lexaria Bioscience Files Innovative New Patent Application Kelowna, British Columbia – November 9, 2017 – Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) a drug delivery platform innovator, announces it has filed a new… https://www.lexariaenergy.com/news/

Zitat:"..Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") announces the filing of a new provisional patent application and stock and option awards.... Lexaria has successfully filed a new provisional patent application with the US Patent and Trademark Office ("USPTO"), No. 62/519,511, with a filing date of June 14, 2017. The new patent application expands Lexaria's lipophilic food and beverage composition claims to now include microwave (dielectric energy) processing as well as heating/dehydration in a vacuum environment....The patent application covers processing of cannabinoids, vitamins, NSAIDs and nicotine. The acceptance by the USPTO of this new application is another step in Lexaria's process of continually strengthening its intellectual property portfolio utilizing all of the most commonly used food processing techniques available. Lexaria believes its current cannabinoid-related patent portfolio to be the broadest of any comparable company in North America.... "ENDE Zitat Source:http://www.otcmarkets.com/stock/LXRP/news/Lexaria-Files-New-Patent-Application?id=162805

::::::::::::::::::: 0,37 $ +5,68% +0,0199 $ In Euro: 0,3291 € | 21:59 Uhr Nasdaq OTC Other ,GrB

Zitat:" "Lexaria") announces it has received US$970,230.05 from the exercise of warrants previously granted. The stock warrants, which otherwise expired on May 15 2017, were exercised at the price of US$0.2273, for a total of 4,268,500 common shares being issued. All warrants are being exercised by third parties who are neither officers nor directors of the Company......"Lexaria's balance sheet is now the strongest it has ever been," commented Chris Bunka, CEO. "We have raised over US$3 million in the past six months, which fully funds the Company's business plans until 2019. We are now focussed on developing our patent portfolio and continuing our work with prospective licensees and resellers."......Following issuance of these common shares, Lexaria will have 66,506,009 common shares issued and outstanding... " ENDE Zitat Source:https://www.bloomberg.com/press-releases/2017-05-19/lexaria-raises-us-1m-from-warrant-exercise